Biomedical/Epigenetic approach to targeting treatments for autism and neurodevelopmental disorders
Dr. Hendren discusses environmental risk factors for autism, how autism presents with many different phenotypes, and how genetics & the environment interact. He touches on biomedical therapeutic strategies, highlighting the challenges to biomedical research before outlining research on therapies including Methyl B12, pancreatic digestive enzymes, melatonin and more. Hendren concludes the presentation underscoring an integrated approach to autism care.
Watch Next
SPARKing New Insight into Autism
Wendy Chung M.D., PH.D.
Wendy Chung is the principle investigator of SPARK (Simons Foundation Powering Autism Research for Knowledge), a research study including over…
Heat and fire: Associations of prenatal wildfire smoke and heat exposures on autism development
David Luglio, PhD
Dr. Luglio presents on his two recent environmental epidemiological studies investigating the associations of wildfire smoke and heat exposure during…
Q&A: Brain Imaging Research in Autism
Marvin Natowicz, MD, PhD, Rajesh Kana, PhD
The accredited educational series jointly provided by Autism Research Institute and Cleveland Clinic Center for Continuing Education reviews the co-occurrence…
Brain Imaging Research in Autism: Promises and Pitfalls
Marvin Natowicz, MD, PhD, Rajesh Kana, PhD
The accredited educational series jointly provided by Autism Research Institute and Cleveland Clinic Center for Continuing Education reviews the co-occurrence…